Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 9, 2015, Pages 16472-16479

  Liu, Zeming ^a   Maimaiti, Yusufu ^a   Yu, Pan ^a   Xiong, Yiquan ^a   Zeng, Wen ^a   Li, Xiaoyu ^a   Song, Haiping ^a   Lu, Chong ^a   Xin, Yue ^a   Zhou, Jing ^a   Zhang, Ning ^a   Ming, Jie ^a   Liu, Chunping ^a   Shi, Wei ^a   Shi, Lan ^a   Li, Xueqin ^a   Nie, Xiu ^a   Huang, Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Body mass index; Prognosis; Thyroid papillary microcarcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER STAGING; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR INVASION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

EID: 84946599854     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bergstrom A, Pisani P, Tenet V, Wolk A and Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91: 421-430.
2. Enger SM, Greif JM, Polikoff J and Press M. Body weight correlates with mortality in early-stage breast cancer. Arch Surg 2004; 139: 954-58; discussion 958-60.
3. You JF, Tang R, Changchien CR, Chen JS, You YT, Chiang JM, Yeh CY, Hsieh PS, Tsai WS, Fan CW and Hung HY. Effect of body mass index on the outcome of patients with rectal cancer receiving curative anterior resection: disparity between the upper and lower rectum. Ann Surg 2009; 249: 783-787.
4. Buschemeyer WC 3rd and Freedland SJ. Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol 2007; 52: 331-343.
5. Liu Z, Wang L, Yi P, Wang CY and Huang T. Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis. Int J Clin Exp Pathol 2014; 7: 932-937.
6. Lin JD. Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer. Med Oncol 2010; 27: 510-518.
7. Chen AY, Jemal A and Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009; 115: 3801-7.
8. Giordano D, Gradoni P, Oretti G, Molina E and Ferri T. Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol 2010; 35: 118-124.
9. Davies L and Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-2167.
10. Liu Z, Xun X, Wang Y, Mei L, He L, Zeng W, Wang CY and Tao H. MRI and ultrasonography detection of cervical lymph node metastases in differentiated thyroid carcinoma before reoperation. Am J Transl Res 2014; 6: 147-154.
11. Sobin LH. Histological typing of thyroid tumours. Histopathology 1990; 16: 513.
12. Zhao Q, Ming J, Liu C, Shi L, Xu X, Nie X and Huang T. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol 2013; 20: 746-752.
13. Kutler DI, Crummey AD and Kuhel WI. Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma. Head Neck 2012; 34: 260-263.
14. Garrel R, Tripodi C, Cartier C, Makeieff M, Crampette L and Guerrier B. Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis 2011; 128: 115-9.
15. Xiang J, Wu Y, Li DS, Shen Q, Wang ZY, Sun TQ, An Y and Guan Q. New clinical features of thyroid cancer in eastern China. J Visc Surg 2010; 147: e53-56.
16. Mijovic T, How J, Pakdaman M, Rochon L, Gologan O, Hier MP, Black MJ, Young J, Tamilia M and Payne RJ. Body mass index in the evaluation of thyroid cancer risk. Thyroid 2009; 19: 467-72.
17. Marcello MA, Sampaio AC, Geloneze B, Vas-ques AC, Assumpcao LV and Ward LS. Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer. Nutr Cancer 2012; 64: 1190-1195.
18. Zhao ZG, Guo XG, Ba CX, Wang W, Yang YY, Wang J and Cao HY. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 2012; 40: 2041-2050.
19. Clero E, Leux C, Brindel P, Truong T, Anger A, Teinturier C, Diallo I, Doyon F, Guenel P and de Vathaire F. Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid 2010; 20: 1285-1293.
20. Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y, Schairer C, Schatzkin A, Shikany JM and Berrington de Gonzalez A. Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev 2011; 20: 464-472.
21. Farfel A, Kark JD, Derazne E, Tzur D, Barchana M, Lazar L, Afek A and Shamiss A. Predictors for thyroid carcinoma in Israel: a national cohort of 1,624,310 adolescents followed for up to 40 years. Thyroid 2014; 24: 987-993.
22. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA and Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014; 384: 755-765.
23. Kim HJ, Kim NK, Choi JH, Sohn SY, Kim SW, Jin SM, Jang HW, Suh S, Min YK, Chung JH and Kim SW. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol (Oxf) 2013; 78: 134-140.
24. Kim SH, Park HS, Kim KH, Yoo H, Chae BJ, Bae JS, Jung SS and Song BJ. Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer. Surg Today 2014.
25. Harari A, Endo B, Nishimoto S, Ituarte PH and Yeh MW. Risk of advanced papillary thyroid cancer in obese patients. Arch Surg 2012; 147: 805-811.
26. Paes JE, Hua K, Nagy R, Kloos RT, Jarjoura D and Ringel MD. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab 2010; 95: 4244-4250.
27. Tresallet C, Seman M, Tissier F, Buffet C, Lupinacci RM, Vuarnesson H, Leenhardt L and Menegaux F. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Surgery 2014; 156: 1145-52.
28. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L and Jorgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005; 90: 4019-4024.
29. Fox CS, Pencina MJ, D'Agostino RB, Murabito JM, Seely EW, Pearce EN and Vasan RS. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med 2008; 168: 587-592.
30. de Luca C and Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008; 582: 97-105.
31. Hursting SD, Lashinger LM, Wheatley KW, Rogers CJ, Colbert LH, Nunez NP and Perkins SN. Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract Res Clin Endocrinol Metab 2008; 22: 659-669.
32. Cheng SP, Chi CW, Tzen CY, Yang TL, Lee JJ, Liu TP and Liu CL. Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery 2010; 147: 847-853.
33. Uddin S, Bavi P, Siraj AK, Ahmed M, Al-Rasheed M, Hussain AR, Ahmed M, Amin T, Alzahrani A, Al-Dayel F, Abubaker J, Bu R and Al-Kuraya KS. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocr Relat Cancer 2010; 17: 191-202.